Anti-CXCR3 Therapy Reduces Harmful Immune Cell Infiltration into the Brain
Key claim: Anti-CXCR3 therapy slows harmful peripheral immune-cell infiltration across the aging blood–brain barrier and yields benefits in a mouse model of neurodegeneration.
Abstract
The immune system of the brain and body are distinct from one another, separated by the blood-brain barrier that lines blood vessels passing through the central nervous system. In health and youth, only small numbers of immune cells from the body pass in the brain, but this number increases considerably with advancing age and the presence of neurodegenerative disease. The blood-brain barrier leaks, and immune cells from the body finding their way into the brain in ever greater numbers are thought to maladaptively promote inflammation, causing dysfunction and damage in brain tissue. Here, researchers find an approach to slowing down this passage of immune cells into the brain, producing benefits in a mouse model of neurodegeneration. CXCR3 is a well-defined chemokine receptor expressed by T […]
Why this matters
Anti-CXCR3 therapy slows harmful peripheral immune-cell infiltration across the aging blood–brain barrier and yields benefits in a mouse model of neurodegeneration.